These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19733411)

  • 1. Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma.
    Li BS; Zhou T; Wang ZT; Li HS; Sun HF; Zhang ZC; Lin HQ; Wei YM; Gong HY; Huang W; Yi Y; Wang LY
    Radiother Oncol; 2009 Dec; 93(3):458-61. PubMed ID: 19733411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed and cisplatin for locally advanced oesophageal squamous cell carcinoma.
    Fu C; Li B; Guo L; Li H; Huang W; Gong H; Sun M; Wang Z; Zhou T; Liu C
    Br J Radiol; 2014 May; 87(1037):20130656. PubMed ID: 24666012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of concurrent selective lymph node late-course accelerated hyperfractionated radiotherapy and S-1 plus cisplatin for locally advanced oesophageal squamous cell carcinoma.
    Li M; Fu C; Zhang W; Huang W; Wang Z; Zhou T; Lin H; Li B
    Br J Radiol; 2016; 89(1060):20150476. PubMed ID: 26891913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed, cisplatin for locally advanced esophageal squamous cell carcinoma.
    Li BS; Gong HY; Huang W; Yi Y; Zhang ZC; Li HS; Wang ZT; Yu JM
    Dis Esophagus; 2011 May; 24(4):251-7. PubMed ID: 21073623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimodality therapy for stage II-III carcinoma of the esophagus: a dose-ranging study of concurrent capecitabine, docetaxel, and thoracic radiotherapy.
    Wood MD; Zaki BI; Gordon SR; Sutton JE; Lisovsky M; Gui J; Bubis JA; Dragnev KH; Rigas JR
    J Thorac Oncol; 2013 Apr; 8(4):487-94. PubMed ID: 23370365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes from chemoradiotherapy for patients with esophageal cancer.
    Pantling AZ; Gossage JA; Mamidanna R; Newman G; Robinson A; Manifold DK; Hale PC
    Dis Esophagus; 2011 Apr; 24(3):172-6. PubMed ID: 21073614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma.
    Czito BG; Kelsey CR; Hurwitz HI; Willett CG; Morse MA; Blobe GC; Fernando NH; D'Amico TA; Harpole DH; Honeycutt W; Yu D; Bendell JC
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1002-7. PubMed ID: 17197129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
    Deenen MJ; Dewit L; Boot H; Beijnen JH; Schellens JH; Cats A
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e201-7. PubMed ID: 23517808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy with docetaxel, cisplatin and capecitabine, followed by combined cetuximab and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck: a phase I-II study.
    Perri F; Muto P; Argenone A; Ionna F; Longo F; Fulciniti F; Sandomenico F; Daponte A; Caponigro F
    Oncology; 2013; 84(4):251-4. PubMed ID: 23428719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus.
    Ohtsu A; Boku N; Muro K; Chin K; Muto M; Yoshida S; Satake M; Ishikura S; Ogino T; Miyata Y; Seki S; Kaneko K; Nakamura A
    J Clin Oncol; 1999 Sep; 17(9):2915-21. PubMed ID: 10561371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phase II clinical trial of concurrent chemoradiotherapy (cisplatin plus 5-fluorouracil) for esophageal cancer].
    Lin Q; Gao XS; Qiao XY; Chen K; Wang YD; Zhou ZG
    Ai Zheng; 2008 Oct; 27(10):1077-81. PubMed ID: 18851788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer.
    Stokes Z; Symonds P; Habeshaw T; Reed N; Curto J; Joynson C; Chan S
    Gynecol Oncol; 2005 Jun; 97(3):790-5. PubMed ID: 15894361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical benefits of concurrent capecitabine and cisplatin versus concurrent cisplatin and 5-flurouracil in locally advanced squamous cell head and neck cancer.
    Gupta S; Khan H; Barik S; Negi MP
    Drug Discov Ther; 2013 Feb; 7(1):36-42. PubMed ID: 23524942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study.
    Wang D; Yang J; Zhu J; Li B; Zhai L; Sun M; Gong H; Zhou T; Wei Y; Huang W; Wang Z; Li H; Zhang Z
    Radiat Oncol; 2013 May; 8():108. PubMed ID: 23638721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer].
    Zhang P; Xie CY; Wu SX
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):773-7. PubMed ID: 18396692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
    J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma.
    Lu JC; Kong C; Tao H
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):710-4. PubMed ID: 20172661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus.
    Stuschke M; Stahl M; Wilke H; Walz M; Oldenburg A; Stüben G; Seeber S; Sack H
    Am J Clin Oncol; 2000 Jun; 23(3):233-8. PubMed ID: 10857883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive chemoradiotherapy with capecitabine and cisplatin in patients with esophageal cancer: a pilot study.
    Lee SJ; Ahn BM; Kim JG; Sohn SK; Chae YS; Moon JH; Lee EB; Kim JC; Park IK; Jeon SW
    J Korean Med Sci; 2009 Feb; 24(1):120-5. PubMed ID: 19270824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.